Belite Bio (BLTE) Tops Q3 EPS by 1c

Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Belite Bio, Inc, ADR (BLTE) PT Raised to $214 at H.C. Wainwright
• Okta upgraded as AI security opportunity boosts outlook
• On Holding AG (ONON) Removed from Raymond James Analyst Current Favorites List